Tag: FDA

News.Bigelow

01/07/2019

Bigelow: Divided Government Means Danger for Pharma in 2019

CHC_washingtonfocus1

12/03/2018

Midterms Delivered Divided Government, New Players

CHC_general1

08/20/2018

FDA Studying Extent of Risk Information in DTC Print Ads

CHC_offLabel

08/13/2018

FDA Finalizing Study of Disclosure Effectiveness in Drug Promotion

CHC_FDA-Regulatory Images1

07/31/2018

FDA Cracks Down on Deceptive Claims for “Vaginal Rejuvenation” Procedures

CHC_Legislative1

06/13/2018

Azar Says FDA Has Authority to Require List Prices in Drug Ads

CHC_general2

05/29/2018

Rawson Shares Short- and Long-term Drug Pricing Fallout at CHC Meeting

News-Jon Bigelow

05/14/2018

Gain Actionable Insights at Rising Leaders Conference on Healthcare Policy

CHC_general1

05/04/2018

White House Drug Pricing Initiative Could Include Moves on Generics/Biosimilars, Demonstration Projects and an End to Part D Rebates, Rawson Says